Li Zhenhua research team - tumor heart disease/nanotherapy/cardiovascular/cardiac toxicity/immune checkpoint inhibitor

38.

T. Xiao et al., “Tailoring therapeutics via a systematic beneficial elements comparison between photosynthetic bacteria-derived OMVs and extruded nanovesicles,” Bioactive Materials, vol. 36, pp. 48–61, Jun. 2024, doi: 10.1016/j.bioactmat.2024.02.025.

MORE+

37.

Luo L, Li Y, Bao Z, Zhu D, Chen G, Li W, Xiao Y, Wang Z, Zhang Y, Liu H, Chen Y, Liao Y, Cheng K, Li Z. Pericardial Delivery of SDF-1 α Puerarin Hydrogel Promotes Heart Repair and Electrical Coupling. Adv Mater. 2023 Sep 4:e2302686. doi: 10.1002/adma.202302686.

MORE+

36.

Wang Z, Li Z, Shi W, Zhu D, Hu S, Dinh PC, Cheng K. A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus. Sci Adv. 2023 Jun 23;9(25):eabo4100. doi: 10.1126/sciadv.abo4100

MORE+

35.

Junjie Yang, Zhen-Ao Zhao, Zhongjian Cheng, Phuong-Uyen Dinh, Ke Huang, Zhenhua Li，extracellular vesicles in cardiovascular diseases，Frontiers in Cardiovascular Medicine,2023

MORE+

34.

Zhu D, Liu S, Huang K, Li J, Mei X, Li Z, Cheng K. Intrapericardial long non-coding RNA-Tcf21 antisense RNA inducing demethylation administration promotes cardiac repair. Eur Heart J. 2023 May 14;44(19):1748-1760. doi: 10.1093/eurheartj/ehad114

MORE+

33.

Zhao E, Xiao T, Tan Y, Zhou X, Li Y, Wang X, Zhang K, Ou C, Zhang J, Li Z, Liu H. Separable Microneedles with Photosynthesis-Driven Oxygen Manufactory for Diabetic Wound Healing. ACS Appl Mater Interfaces. 2023 Feb 15;15(6):7725-7734. doi: 10.1021/acsami.2c18809. Epub 2023 Feb 2.

MORE+

32.

Che, R., Han, D., Wang, F. Li Z, et al. Liposome-coated CaO2 nanoblockers for enhanced checkpoint blockade therapy by inhibiting PD-L1 de novo biosynthesis. Nano Res. (2023). https://doi.org/10.1007/s12274-022-5362-7

MORE+

31.

Han D, Zhang X, Ma Y, Yang X, Li Z. The development of live microorganism-based oxygen shuttles for enhanced hypoxic tumor therapy. Mater Today Bio. 2022 Dec 10;18:100517. doi: 10.1016/j.mtbio.2022.100517. PMID: 36578285; PMCID: PMC9791452.

MORE+

30.

PD-L1 antibodies-armed exosomal vaccine for enhanced cancer immunotherapy by simultaneously in situ activating T cells and blocking PD-1/PD-L1 axis,Extracellular Vesicle,Volume 1,2022.

MORE+

29.

Zhenzhen Wang, Kristen D. Popowski, Dashuai Zhu, Blanca López de Juan Abad, Xianyun Wang, Mengrui Liu, Halle Lutz, Nicole De Naeyer, Todd C. DeMarco, Thomas N. Denny, Phuong-Uyen C. Dinh, Zhenhua Li*, Ke Cheng*. An Inhalable Virus-Like Particle Vaccine against SARS-CoV-2 Based on RBD Conjugated Exosomes. Nature Biomedical Engineering, 2022. 6, 791–805

MORE+